GLP-1 receptor agonists are effective for treating obesity and diabetes, but the high cost and high rates of gastrointestinal adverse effects can lead to treatment cessation and subsequent weight regain, the researchers explained
[DOI] [PMC free article] [PubMed] [Google Scholar] 173
After working with dozens of clients on semaglutide and tirzepatide over the past two years in New York City, Ive built a clear picture of what changes, what doesnt, and exactly how to structure your training and recovery to keep progressing while on GLP-1 medication
Adherence concerns: Many people stop treatment early, leading insurers to question the long-term return on investment for these medications
Oats and oat derivatives have been consumed for generations and are a common nutritional staple
However, we do recommend all patients consider taking a break at 6 months for at least one month off